|
|
Volumn 6, Issue 10, 2005, Pages
|
|
Digital drug discovery
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
ARACHIDONATE 15 LIPOXYGENASE;
ASTEMIZOLE;
BETA 2 ADRENERGIC RECEPTOR;
BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
CYTOCHROME P450;
NEW DRUG;
PLASMA PROTEIN;
THIOPURINE METHYLTRANSFERASE;
ACCURACY;
ANTIINFLAMMATORY ACTIVITY;
CONFERENCE PAPER;
CYTOTOXICITY;
DNA MICROARRAY;
DRUG ABSORPTION;
DRUG DETERMINATION;
DRUG EXCRETION;
DRUG METABOLISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SCREENING;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG WITHDRAWAL;
ENZYME ACTIVITY;
ENZYME INDUCTION;
FOOD AND DRUG ADMINISTRATION;
GENETIC VARIABILITY;
HUMAN;
HUMAN GENOME PROJECT;
LIVER TOXICITY;
NONHUMAN;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PROTEOMICS;
QT PROLONGATION;
RELIABILITY;
REPRODUCIBILITY;
RNA INTERFERENCE;
SENSITIVITY AND SPECIFICITY;
SINGLE NUCLEOTIDE POLYMORPHISM;
BIOLOGY;
COMBINATORIAL CHEMISTRY;
COMPUTER SIMULATION;
DRUG DESIGN;
COMBINATORIAL CHEMISTRY TECHNIQUES;
COMPUTATIONAL BIOLOGY;
COMPUTER SIMULATION;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
PHARMACOGENETICS;
|
|
EID: 27244450109
PISSN: 14656906
EISSN: None
Source Type: Journal
DOI: 10.1186/gb-2005-6-10-348 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
